General Electric sells off BioPharma business to Danaher in $21.4B deal
Monday, February 25, 2019 - 09:20
in Mathematics & Economics
General Electric said Monday it's selling off its BioPharma business for more than $21 billion, in a move that cuts out significant debt for the conglomerate.